SWS Partners lifted its position in shares of Confluent, Inc. (NASDAQ:CFLT - Free Report) by 99.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 107,330 shares of the company's stock after buying an additional 53,428 shares during the period. SWS Partners' holdings in Confluent were worth $2,516,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of CFLT. Cloud Capital Management LLC purchased a new position in shares of Confluent during the 1st quarter valued at about $26,000. Versant Capital Management Inc raised its holdings in shares of Confluent by 2,458.2% during the 1st quarter. Versant Capital Management Inc now owns 1,714 shares of the company's stock valued at $40,000 after buying an additional 1,647 shares in the last quarter. Banque Transatlantique SA purchased a new position in shares of Confluent during the 1st quarter valued at about $43,000. SVB Wealth LLC purchased a new position in shares of Confluent during the 1st quarter valued at about $54,000. Finally, GAMMA Investing LLC raised its holdings in shares of Confluent by 26.8% during the 1st quarter. GAMMA Investing LLC now owns 3,128 shares of the company's stock valued at $73,000 after buying an additional 661 shares in the last quarter. 78.09% of the stock is owned by hedge funds and other institutional investors.
Confluent Price Performance
Shares of CFLT stock opened at $20.01 on Thursday. The firm has a market cap of $6.90 billion, a P/E ratio of -21.29 and a beta of 0.97. Confluent, Inc. has a fifty-two week low of $15.64 and a fifty-two week high of $37.90. The business's 50 day moving average price is $21.15 and its 200-day moving average price is $22.99. The company has a debt-to-equity ratio of 1.03, a quick ratio of 3.98 and a current ratio of 3.98.
Confluent (NASDAQ:CFLT - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.01. The firm had revenue of $282.29 million for the quarter, compared to analyst estimates of $278.32 million. Confluent had a negative return on equity of 27.34% and a negative net margin of 29.27%.The business's quarterly revenue was up 20.1% compared to the same quarter last year. During the same period last year, the company earned $0.06 EPS. Confluent has set its Q3 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.360-0.360 EPS. On average, equities research analysts anticipate that Confluent, Inc. will post -0.83 earnings per share for the current year.
Insider Transactions at Confluent
In other news, CFO Rohan Sivaram sold 5,000 shares of Confluent stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $20.00, for a total value of $100,000.00. Following the sale, the chief financial officer directly owned 631,596 shares in the company, valued at approximately $12,631,920. This trade represents a 0.79% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CRO Ban Ryan Norris Mac sold 15,200 shares of Confluent stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $17.01, for a total value of $258,552.00. Following the completion of the sale, the executive owned 397,345 shares in the company, valued at approximately $6,758,838.45. This represents a 3.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 587,421 shares of company stock worth $10,554,916. Corporate insiders own 9.20% of the company's stock.
Wall Street Analyst Weigh In
CFLT has been the topic of a number of research reports. Royal Bank Of Canada decreased their price objective on Confluent from $28.00 to $25.00 and set an "outperform" rating on the stock in a report on Thursday, July 31st. Oppenheimer decreased their price objective on Confluent from $32.00 to $26.00 and set an "outperform" rating on the stock in a report on Thursday, July 31st. Cowen lowered Confluent from a "buy" rating to a "hold" rating in a research report on Thursday, July 31st. Barclays reduced their price target on Confluent from $31.00 to $24.00 and set an "overweight" rating on the stock in a research report on Friday, August 1st. Finally, Stephens began coverage on Confluent in a research report on Friday, July 18th. They set an "overweight" rating and a $31.00 price target on the stock. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $27.36.
View Our Latest Analysis on CFLT
About Confluent
(
Free Report)
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
Further Reading
Want to see what other hedge funds are holding CFLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Confluent, Inc. (NASDAQ:CFLT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Confluent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.
While Confluent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.